Rosetta Licenses Resolver to Immunex | GenomeWeb

NEW YORK, Feb 26 - Rosetta Inpharmatics has licensed its Rosetta Resolver Expression Data Analysis System to Immunex, Rosetta said Monday.

The Resolver is a bioinformatics platform that analyzes gene expression. It can be used with a variety of microarrays from different manufacturers. including Affymetrix GeneChips and Agilent DNA arrays. Rosetta released the latest version of the system last quarter, and has granted Agilent Technologies sole distribution rights to it. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.